Anti-Bevacizumab ELISA Kit
PRINCIPLE OF THE ASSAY This assay employs the quantitative sandwich enzyme immunoassay technique. Bevacizumab has been pre-coated onto a microplate. Samples or standards are pipetted into microwells and Anti-Bevacizumab will be captured by immobilized Bevacizumab. After washing away any unbound substances, a biotin-labeled Bevacizumab is added to the wells. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of Anti-Bevacizumab bound in the initial step. The color development is stopped and the intensity of the color is measured.
Product Specifications
Product Name Alternative
12-IgG1, F (ab) -12 IgG1, Fab-12 IgG1, rhuMAb-VEGF, ABP 215, CAS: 216974-75-3
Applications
Used for the quantitative determination of Anti-Bevacizumab concentration in serum and plasma.
Stability
When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%.
Shipping Conditions
2-8 °C
Notes
For Research Use Only.
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items